Subsequently, NTRK1 fusions have been detected at a frequency of 12% in papillary thyroid cancer with TPM3-NTRK1 being the most common gene rearrangement [5–7]. This evidence concerns the gene NTRK1 and thyroid gland papillary carcinoma.